Cite

HARVARD Citation

    Janni, W. et al. (2015). Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancer. Breast. 24 (6), pp. 769-773. [Online]. 
  
Back to record